Evidence map›Paper›PMID 41832333›Full record

ArticleJournal of cancer survivorship : research and practice2026

Fatigue among adult survivors of childhood cancer: findings from the French Childhood Cancer Survivor Study.

Médéa Locquet, Duc Hoan Vu, Rodrigue Allodji, Neige Journy, Chiraz El-Fayech, Charlotte Demoor-Goldschmidt, Laura Lenez, Cécile Thomas-Teinturier, Stéphanie Bolle, Nadia Haddy and 12 more

Erratum issued Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01620372 (Constitution d'Une Cohorte Nationale rétrospective de Survivants d'un Cancer Solide de l'Enfant diagnostiqué Avant 2000), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01620372 recruitingnot on this map

Constitution d'Une Cohorte Nationale rétrospective de Survivants d'un Cancer Solide de l'Enfant diagnostiqué Avant 2000

TypeobservationalSponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2011 to 2031Enrolled18,000ConditionsChildhood Solid Tumor
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Médéa LocquetInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Duc Hoan VuInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Rodrigue AllodjiInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Neige JournyInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Chiraz El-FayechGustave Roussy, Villejuif, France.
Charlotte Demoor-GoldschmidtInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Laura LenezInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Cécile Thomas-TeinturierInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Stéphanie BolleCentro de Protonterapia, Grupo QuironSalud, Madrid, Spain.
Nadia HaddyInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Giao Vu-BezinInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Agnès DumasIRD, ISSPAM, SESSTIM (Economic and Social Sciences of Health and Medical Information Processing), INSERM, Aix Marseille UnivCALIPSO Team, Marseille, France.
David RajaoneraInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
Nicolas BougasUMR 1123, Université de Paris, ECEVE, INSERM (National Institute for Health and Medical Research), Paris, France.
Jacques GrillGustave Roussy, Villejuif, France.
Christelle DufourGustave Roussy, Villejuif, France.
Hélène PacquementInstitut Curie, Paris, France.
Ibrahima DialloInserm Research Unit 1355 - Molecular Radiotherapy and Innovative Therapeutics - (RAMO-IT), Université Paris-Saclay, Gustave Roussy, Villejuif, France.
Jean Bernard Le-ProvostInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.
François DozInstitut Curie, Paris, France.
Brice FresneauInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France. brice.fresneau@gustaveroussy.fr.ORCID http://orcid.org/0000-0001-7603-7828
Florent De VathaireInserm Research Unit 1018 for Epidemiology and Health Population (CESP), Université Paris-Saclay, UVSQ, Gustave Roussy, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFatigue is a prevalent and late effect among childhood cancer survivors (CCSs). Few large studies have comprehensively evaluated its prevalence and determinants. Identifying risk factors for fatigue and severe fatigue (SF) is crucial to improving survivorship care. This study assessed the prevalence of fatigue and SF, as well as demographic, clinical, and treatment-related predictors in the French Childhood Cancer Survivor Study (FCCSS).

methodsThis cross-sectional analysis included adult 5-year CCSs diagnosed before age 21 (1946-2000) in the FCCSS cohort. Fatigue was measured using the French Multidimensional Fatigue Inventory (MFI-20); SF was defined as a total score > 60. Associations with sex, age, cancer type, treatment, and social deprivation were estimated using multivariable regressions. Analyses were stratified by central nervous system (CNS) vs. non-CNS tumors and compared to general population norms.

resultsAmong 3170 CCSs, fatigue scores exceeded population norms from age 30, with women affected earlier and more severely. General (10.0 ± 4.2) and physical fatigue (9.6 ± 4.2) were the most pronounced dimensions, increasing with age and peaking at ≥ 50 years. Higher fatigue scores were independently associated with female sex, obesity, older age, and CNS tumor history. SF affected 16% of CCSs, more frequently in women (OR = 1.30), obese survivors (OR = 2.40), CNS tumor survivors (OR = 3.27), hematologic tumor survivors (OR = 1.46), and radiotherapy exposure (OR = 1.46).

conclusionFatigue remains a common, persistent late effect in CCSs. Female sex, older age, CNS tumors, and radiotherapy were strong predictors, underscoring the needs for targeted screening and long-term management.

Indexed as

Cancer survivorship careCancer therapy late effectsChildhood cancer survivorsFatigueQuality of lifeRadiotherapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.